The report "Europe Probiotics Market by Product Type (Functional Food & Beverages, Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Global Forecast to 2030" is estimated to be USD 15.73 billion in 2025 and is projected to reach USD 20.56 billion by 2030, registering at a CAGR of 5.5% from 2025 to 2030.
Browse 200 market data Tables and 130 Figures spread through 250 Pages and in-depth TOC on "Europe Probiotics Market - By Product Type (Functional Food & Beverages, Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-probiotics-market-198127085.html
The probiotics market in Europe is steadily growing as consumers and healthcare providers increasingly pay attention to digestive health, immunity, and overall wellness. Probiotics are being used in functional foods and beverages, dietary supplements, pharmaceuticals, and animal nutrition. The demand is supported by trends toward clean-label and natural products in Germany, France, the UK, Italy, and the Nordics. Enhancements in fermentation processes, increased strain stability, and heavier clinical backing have built ingredient credibility and increased acceptance. Simultaneously, factors such as the rise in awareness of microbiomes, the acceptance of prophylactic healthcare, and the incorporation of probiotics into common foods like yogurts and fermented drinks are promoting the usage of probiotics. As health-focused choices are gaining ground among consumers, probiotics are playing an important role in the growth of the European market.
By ingredient, bacteria segment to account for largest market share
By ingredient, the bacteria segment is estimated to hold the largest share of the probiotics market in Europe. Common strains are Lactobacillus, Bifidobacterium, and Streptococcus, which are applied in functional foods, beverages, dietary supplements, and infant formulas. Manufacturers prefer them for their proven benefits in digestion, immunity, and gut balance. These strains are supported by robust clinical evidence and regulatory approvals in Europe. They also offer stable formulations. Bacteria-based probiotics are incorporated in products such as yogurt, fermented dairy drinks, capsules, and children’s nutrition products. They are preferred for their consistent quality, good survival rates, and safe use. Europe is capable of large-scale production and distribution thanks to its developed fermentation capacity and well-functioning cold-chain systems. Demand for new microbial sources is growing; however, bacterial strains have a competitive edge over yeast and fungi due to price advantages, strong consumer confidence, and well-established scientific backing. This category is expected to stay dominant with the increasing demand for preventive health and microbiome-related nutrition across the region.
By end user, human segment to account for largest market share
By end user, the human segment is estimated to account for the largest share of the probiotics market in Europe. Consumers are increasingly opting for probiotics to ease digestion, boost immunity, and improve general health. Human-consumed products include dietary supplements, functional dairy, fermented drinks, and fortified foods. The demand for these products is gaining traction as awareness regarding gut health and preventive care increases. These products cater to diverse daily needs. They promote gut health while providing added benefits like enhancing nutrient absorption and supporting immunity. Human-oriented product lines are evolving from manufacturers with strain-based formulations, improved stability, and clean-label ingredients. This improves product functionality, taste, and shelf life. Retailers, pharmacies, and online sellers are broadening their dietary probiotic offerings to fulfill the consumers’ demand for such accessible, science-supported health products that are becoming increasingly popular. As the connection between gut health and overall well-being continues to solidify, human end-users are predicted to remain an important driver of market growth.
By country, Russia to account for significant market share
Russia is estimated to hold a significant share of the probiotics market in Europe. The demand for probiotic products is mainly driven by health-related consumer interests in digestion, immunity, and the gut. Gradual shifts in the consumer's perception of nutrition also play a role in the demand for probiotics. There is a growing middle-income population that, along with wider access to modern retail, is commissioning probiotic foods, beverages, and supplements. From supermarkets to pharmacies and online platforms, the availability of probiotics is broadening for easy access across major cities and second-tier locations. Russia has a long-standing cultural tradition with fermented dairy products like kefir and ryazhenka, providing a strong base for introducing value-added probiotic products. Both local and global companies are formulating products suited to regional taste and price expectations. Clearer regulations concerning health claims and product quality have made it easier for firms to instill consumer trust and to ensure consistency in their quality. As lifestyle-related digestive issues become more frequent and preventive health becomes a priority, the demand for probiotics in Russia is expected to keep rising. These elements collectively lead to the conclusion that the country will be one of the main contributors to the growth of the probiotics market in Europe as a whole.
The report profiles key players such as Danone S.A. (France), Probi AB (Sweden), Nestlé S.A. (Switzerland), Kerry Group plc (Ireland), BioGaia AB (Sweden), Bio-K Plus International Inc. (Canada), Daflorn Probiotics Ltd. (Bulgaria), Yakult Honsha Co., Ltd. (Japan), Arla Foods (Denmark), and AB-Biotics S.A. (Spain).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com